Digitally Assessed Long COVID Symptomatology Is Associated With Lymphocyte Mitochondrial Dysfunction and Altered Immune Potential - Summary - MDSpire

Digitally Assessed Long COVID Symptomatology Is Associated With Lymphocyte Mitochondrial Dysfunction and Altered Immune Potential

  • By

  • Vasile Mihai Sularea

  • Liam Townsend

  • Cian Reid

  • Andreea V Atanasescu

  • Adam H Dyer

  • Federica Giangrazi

  • Roman Rocha Lawrence

  • Manoj Sivan

  • Barry Moran

  • Derek G Doherty

  • Niall P Conlon

  • Aideen Long

  • Cliona O’Farrelly

  • November 17, 2025

  • 0 min

Share

Objective:

To investigate the relationship between mitochondrial function in immune cells and symptom severity in patients with long COVID.

Key Findings:
  • Patients with long COVID exhibited significant symptom burden compared to their health state before infection.
  • Decreased mitochondrial membrane potential was observed in CD56bright natural killer cells and CD4+ lymphocytes associated with specific symptoms.
  • Lower IFN-γ production in response to LPS stimulation and impaired IFN-β and IL-10 responses linked to worsening cough and cognitive functions.
Interpretation:

The findings suggest that mitochondrial dysfunction in immune cells and altered cytokine responses are associated with the severity of long COVID symptoms, indicating potential biomarkers for future therapeutic strategies.

Limitations:
  • Small sample size of 27 patients with long COVID.
  • Study focused on specific immune cell populations, which may not represent the entire immune response.
Conclusion:

The study highlights the importance of mitochondrial function and immune dysregulation in understanding long COVID, paving the way for targeted therapeutic approaches.

Original Source(s)

Digitally Assessed Long COVID Symptomatology Is Associated With Lymphocyte Mitochondrial Dysfunction and Altered Immune Potential

  • by Vasile Mihai Sularea, Liam Townsend, Cian Reid, Andreea V Atanasescu, Adam H Dyer, Federica Giangrazi, Roman Rocha Lawrence, Manoj Sivan, Barry Moran, Derek G Doherty, Niall P Conlon, Aideen Long, Cliona O’Farrelly

  • November 17, 2025

Related Content

MEK1/2 inhibitor ATR-002 reshapes host transcriptome and modulates immune regulatory genes in SARS-CoV-2 infection

Explainable machine learning-based mortality risk stratification for older adults with COVID-19: pinpointing core immunological biomarkers and revealing dose-threshold effects

Post-acute metabolic changes and risk of new-onset diabetes following COVID-19: a systematic review and meta-analysis